Study on the chemodrug-induced effect in nasopharyngeal carcinoma cells using laser tweezer Raman spectroscopy.
Journal
Biomedical optics express
ISSN: 2156-7085
Titre abrégé: Biomed Opt Express
Pays: United States
ID NLM: 101540630
Informations de publication
Date de publication:
01 Apr 2020
01 Apr 2020
Historique:
received:
21
01
2020
revised:
22
02
2020
accepted:
28
02
2020
entrez:
29
4
2020
pubmed:
29
4
2020
medline:
29
4
2020
Statut:
epublish
Résumé
To explore the effect in nasopharyngeal carcinoma (NPC) cells after treatment with chemodrugs, Raman profiles were characterized by laser tweezer Raman spectroscopy. Two NPC cell lines (CNE2 and C666-1) were treated with gemcitabine, cisplatin, and paclitaxel, respectively. The high-quality Raman spectra of cells without or with treatments were recorded at the single-cell level with label-free laser tweezers Raman spectroscopy (LTRS) and analyzed for the differences of alterations of Raman profiles. Tentative assignments of Raman peaks indicated that the cellular specific biomolecular changes associated with drug treatment include changes in protein structure (e.g. 1655 cm
Identifiants
pubmed: 32341850
doi: 10.1364/BOE.388785
pii: 388785
pmc: PMC7173897
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1819-1833Informations de copyright
© 2020 Optical Society of America under the terms of the OSA Open Access Publishing Agreement.
Déclaration de conflit d'intérêts
The authors declare that there are no conflicts of interest related to this article.
Références
J Biophotonics. 2013 Jan;6(1):36-48
pubmed: 23175434
Nanomedicine. 2019 Nov;22:102100
pubmed: 31648038
Analyst. 2019 Aug 5;144(16):4733-4749
pubmed: 31199412
J Biophotonics. 2009 Feb;2(1-2):47-69
pubmed: 19343685
Analyst. 2011 Jul 7;136(13):2718-25
pubmed: 21562654
Cancers (Basel). 2017 Nov 16;9(11):
pubmed: 29144412
Cell Cycle. 2016 May 2;15(9):1227-33
pubmed: 27104236
Biomed Opt Express. 2010 Oct 10;1(4):1138-1147
pubmed: 21258536
Drug Resist Updat. 2015 Nov;23:55-68
pubmed: 26690340
Clin Epigenetics. 2018 Feb 27;10(1):26
pubmed: 30359298
Nat Commun. 2017 Feb 01;8:14053
pubmed: 28146149
Drug Des Devel Ther. 2016 Mar 31;10:1299-306
pubmed: 27099475
Opt Express. 2011 Jul 4;19(14):13565-77
pubmed: 21747512
J Exp Clin Cancer Res. 2019 Jan 8;38(1):11
pubmed: 30621723
Biomed Opt Express. 2019 Jan 09;10(2):500-513
pubmed: 30800495
Biomed Opt Express. 2018 Jun 27;9(7):3413-3423
pubmed: 29984106
Analyst. 2011 Jun 21;136(12):2450-63
pubmed: 21519610
Lancet. 2019 Jul 6;394(10192):64-80
pubmed: 31178151
Biopolymers. 2009 Feb;91(2):132-9
pubmed: 18825777
N Engl J Med. 2019 Sep 19;381(12):1124-1135
pubmed: 31150573
Biomed Opt Express. 2019 Dec 23;11(1):388-405
pubmed: 32010523
Analyst. 2019 Feb 21;144(4):1309-1325
pubmed: 30560265
J Biophotonics. 2018 Jan;11(1):
pubmed: 28703437
Appl Spectrosc. 2007 Nov;61(11):1225-32
pubmed: 18028702
Anal Chem. 2015 Jul 21;87(14):7297-304
pubmed: 26075314
J Biophotonics. 2019 Mar;12(3):e201800332
pubmed: 30485680
Ann Oncol. 2019 Oct 1;30(10):1630-1637
pubmed: 31373615
Biomed Opt Express. 2018 Feb 02;9(3):984-993
pubmed: 29541498
J Biophotonics. 2019 Mar;12(3):e201800328
pubmed: 30414254
J Biomed Opt. 2013 May;18(5):56010
pubmed: 23698321
J Am Chem Soc. 2013 Mar 27;135(12):4688-91
pubmed: 23469948
Sci Rep. 2017 May 23;7(1):2296
pubmed: 28536451
Chem Soc Rev. 2016 Apr 7;45(7):1819-49
pubmed: 26497570
Analyst. 2016 Feb 21;141(4):1339-46
pubmed: 26738697
Theranostics. 2017 Aug 18;7(14):3517-3526
pubmed: 28912892
J Biomed Opt. 2012 Aug;17(8):081418
pubmed: 23224179
Chem Rev. 2018 May 23;118(10):4946-4980
pubmed: 29638112
Med Res Rev. 2016 Mar;36(2):300-12
pubmed: 26332739
Analyst. 2020 Jan 21;145(2):385-392
pubmed: 31844853
Cancer Cell. 2017 Jul 10;32(1):71-87.e7
pubmed: 28697344
Nat Biotechnol. 2008 Mar;26(3):303-4
pubmed: 18327243
J Antimicrob Chemother. 2016 Jun;71(6):1540-6
pubmed: 26861569
Anal Chem. 2014 Nov 4;86(21):10909-16
pubmed: 25268694
Int J Mol Sci. 2018 Mar 07;19(3):
pubmed: 29518977
J Urol. 2015 Mar;193(3):1016-22
pubmed: 25229559
Pharmacol Rev. 2012 Jul;64(3):706-21
pubmed: 22659329
Oncogene. 2012 Apr 12;31(15):1869-83
pubmed: 21892204
Cancer Chemother Pharmacol. 2017 Nov;80(5):909-917
pubmed: 28741098